Hemodynamic Monitoring & Blood Pressure Targets

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Hemodynamic Monitoring & Blood Pressure Targets

Key Takeaways Explain This Topic AI

Document heart-versus-head arterial reference level when calculating CPP; a hydrostatic correction is required when comparing measurements made at different heights.

Arterial line damping artifacts distort pulse pressures: overdamping falsely depresses systolic blood pressure and elevates diastolic pressure without altering M A P MAP M A P , whereas underdamping generates resonant overshoot spikes that artificially elevate systolic pressure.

PPV and SVV have important validity limits, including spontaneous effort, low tidal volume, arrhythmia, and right-heart disease; use another suitable test when these limits matter.

Disease-specific blood pressure guidelines require tight adherence: acute ischemic stroke prior to thrombolysis requires < 185 / 110 mmHg < 185/110\text{ mmHg} < 185/110 mmHg and post-reperfusion < 180 / 105 mmHg < 180/105\text{ mmHg} < 180/105 mmHg ; acute intracerebral hemorrhage requires rapid reduction to 130 – 150 mmHg 130\text{--}150\text{ mmHg} 130 – 150 mmHg while avoiding S B P < 130 mmHg SBP < 130\text{ mmHg} SBP < 130 mmHg ; and severe traumatic brain injury requires S B P ≥ 100 – 110 mmHg SBP \ge 100\text{--}110\text{ mmHg} SBP ≥ 100 – 110 mmHg and C P P 60 – 70 mmHg CPP\ 60\text{--}70\text{ mmHg} CPP 60 – 70 mmHg .

The 2023 aSAH guideline recommends avoiding severe hypertension, hypotension, and variability before securing, without selecting one universal SBP target; symptomatic DCI may justify individualized pressure elevation.

Last updated: October 2026

Hemodynamic Monitoring & Blood Pressure Targets

Hemodynamic management in the neuro-intensive care unit operates under a fundamental imperative: preserving adequate cerebral perfusion while preventing secondary cerebral edema, hemorrhagic expansion, or systemic organ injury. Because acute brain injury abolishes normal cerebral autoregulation in affected tissue, cerebral blood flow ( C B F CBF CBF ) becomes passively dependent on systemic mean arterial pressure ( M A P MAP M A P ). Clinicians must understand the physical principles of invasive hemodynamic monitors, recognize signal artifacts, assess volume responsiveness dynamically, and tailor blood pressure targets to specific neuropathologies.

Invasive Arterial Blood Pressure Monitoring

Continuous arterial blood pressure monitoring via an indwelling arterial catheter is mandatory for unstable neuro-ICU patients receiving vasoactive infusions, undergoing induced hypertension, or requiring frequent arterial blood gas sampling.

Vascular Access Sites: Radial vs. Femoral

Radial Artery: The most common cannulation site due to accessibility, ease of maintenance, and dual collateral palmar circulation (evaluated historically via Allen's test or ultrasound). However, due to distal vascular impedance and wave reflection, peripheral radial arterial waveforms exhibit pulse wave amplification —manifesting as higher systolic blood pressure ( S B P SBP SBP ) and lower diastolic blood pressure ( D B P DBP D BP ) than central aortic pressures, although M A P MAP M A P remains relatively concordant.

Femoral Artery: Closer to the central aorta, providing a more reliable reflection of central aortic pressure in states of severe distributive shock or high-dose vasopressor therapy, where intense peripheral vasoconstriction and vasospasm can cause severe peripheral damping or underestimation of central MAP. Femoral lines carry higher risks of catheter-related thrombosis and retroperitoneal hemorrhage during placement.

Transducer Leveling and the Hydrostatic Gradient

In general critical care, arterial transducers are zeroed and leveled to the phlebostatic axis (the fourth intercostal space at the mid-axillary line), approximating the level of the right atrium. However, neurocritical care patients routinely have the head of the bed ( H O B HOB H OB ) elevated to 30 ∘ 30^\circ 3 0 ∘ to facilitate intracranial venous drainage and reduce intracranial pressure ( I C P ICP I CP ).

When the H O B HOB H OB is elevated 30 ∘ 30^\circ 3 0 ∘ , the brain is elevated approximately 13 – 15 cm 13\text{--}15\text{ cm} 13 – 15 cm above the right atrium. Because blood has a specific gravity similar to water, this height difference creates a hydrostatic column gradient: Δ P = ρ ⋅ g ⋅ h ≈ h (in cm) 1.36 ≈ 10 – 11 mmHg \Delta P = \rho \cdot g \cdot h \approx \frac{h\text{ (in cm)}}{1.36} \approx 10\text{--}11\text{ mmHg} Δ P = ρ ⋅ g ⋅ h ≈ 1.36 h (in cm) ​ ≈ 10 – 11 mmHg

If the arterial line transducer remains leveled at the phlebostatic axis, it measures the pressure entering the ascending aorta, overestimating the effective arterial pressure arriving at the circle of Willis by 10 – 11 mmHg 10\text{--}11\text{ mmHg} 10 – 11 mmHg .

Important

To accurately calculate Cerebral Perfusion Pressure ( C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP ), the arterial pressure transducer must be leveled to the foramen of Monro , externally marked by the external auditory meatus (tragus) . Calculating C P P CPP CPP using a phlebostatic axis M A P MAP M A P in an upright patient falsely reassures the clinician with an artificially elevated C P P CPP CPP , potentially masking critical cerebral ischemia:

• C P P = M A P tragus − I C P CPP = MAP_{\text{tragus}} - ICP CPP = M A P tragus ​ − I CP
• Arterial Waveform Damping and the Fast-Flush Test

Accurate pressure measurement depends on an optimal balance between the natural frequency ( f n f_n f n ​ ) of the fluid-tubing-transducer circuit and its damping coefficient ( ζ \zeta ζ ). Damping artifacts are evaluated at the bedside using the fast-flush square wave test (rapidly opening and releasing the high-pressure flush valve):

Waveform State Bedside Appearance Fast-Flush Response Pressure Artifact Common Etiologies Corrective Action

Optimally Damped Sharp systolic upstroke, clear dicrotic notch 1.5 to 2 post-flush oscillations before baseline Accurate S B P SBP SBP , D B P DBP D BP , and M A P MAP M A P Ideal fluid-filled circuit None; maintain closed system

Overdamped Slurred upstroke, absent dicrotic notch, rounded peak < 1 < 1 < 1 oscillation; slow, sluggish return to baseline Falsely low SBP , falsely high DBP ; M A P MAP M A P preserved Air bubbles, fibrin/clot on tip, kinks, compliant tubing Purge air bubbles, aspirate clot, straighten tubing

Underdamped (Resonant) Narrow, exaggerated systolic spike; multiple ringing notches > 3 > 3 > 3 rapid oscillations before baseline Falsely high SBP , falsely low DBP ; M A P MAP M A P preserved Excessively stiff tubing, long extension tubing, catheter whip Remove extra stopcocks, shorten tubing, add damping device

Note

In both overdamped and underdamped systems, electronic integration of the area under the pressure curve allows M A P MAP M A P to remain remarkably stable and accurate despite significant distortions in systolic and diastolic peaks. When titrating vasopressors to M A P MAP M A P , the impact of minor damping is modest; however, when titrating antihypertensives to strict S B P SBP SBP thresholds (e.g., in acute stroke or ICH), damping artifacts can lead to dangerous over- or undertreatment.

Dynamic Parameters of Volume Responsiveness

Static measures of preload—such as Central Venous Pressure ( C V P CVP C V P ) or pulmonary capillary wedge pressure ( P C W P PCWP PC W P )—correlate poorly with changes in stroke volume. Neurocritical care has shifted toward dynamic physiologic indices based on cardiopulmonary interactions during positive pressure mechanical ventilation.

Pulse Pressure Variation (PPV) and Stroke Volume Variation (SVV)

During mechanical inspiration, positive intrathoracic pressure compresses the pulmonary capillary bed, transiently boosting left ventricular ( L V LV L V ) preload and increasing stroke volume. Concurrently, positive pleural pressure decreases systemic venous return, dropping right ventricular ( R V RV R V ) filling. Two to three beats later (during mechanical expiration), this reduced R V RV R V output traverses the lungs and reaches the left heart, causing a cyclic drop in L V LV L V stroke volume and arterial pulse pressure: P P V ( % ) = 100 × P P max ⁡ − P P min ⁡ ( P P max ⁡ + P P min ⁡ ) / 2 PPV\ (\%) = 100 \times \frac{PP_{\max} - PP_{\min}}{(PP_{\max} + PP_{\min}) / 2} PP V ( % ) = 100 × ( P P m a x ​ + P P m i n ​ ) /2 P P m a x ​ − P P m i n ​ ​

A P P V ≥ 12 – 13 % PPV \ge 12\text{--}13\% PP V ≥ 12 – 13% or S V V ≥ 10 – 12 % SVV \ge 10\text{--}12\% S VV ≥ 10 – 12% strongly predicts an increase in cardiac output ( ≥ 10 – 15 % \ge 10\text{--}15\% ≥ 10 – 15% ) following a fluid bolus (fluid responsiveness).

Strict Physiological Prerequisites for PPV and SVV

Dynamic respiratory variation indices are reliable only when all of the following criteria are met:

Full Mechanical Ventilation: Zero spontaneous respiratory efforts (spontaneous breaths induce irregular negative intrathoracic swings that invalidate the cyclic calculation).

Adequate Tidal Volume: Delivered tidal volume must be ≥ 8 mL/kg \ge 8\text{ mL/kg} ≥ 8 mL/kg of predicted body weight ( P B W PBW PB W ). Low-tidal-volume lung-protective ventilation ( 6 mL/kg 6\text{ mL/kg} 6 mL/kg ) produces insufficient intrathoracic pressure swings, yielding false-negative P P V PPV PP V values.

Regular Cardiac Rhythm: Sinus rhythm must be present. Arrhythmias (e.g., atrial fibrillation, frequent premature ventricular contractions) introduce stroke volume variation independent of respiration.

Normal Thoraco-Abdominal Mechanics: Closed thorax (open sternotomy abolishes pleural pressure transmission) and absence of severe intra-abdominal hypertension.

The Passive Leg Raise (PLR) Challenge

The passive leg raise ( P L R PLR P L R ) serves as a reversible, endogenous "autotransfusion" of approximately 300 mL 300\text{ mL} 300 mL of blood from the lower extremities and splanchnic venous reservoir into the cardiac chambers.

Advantages and limits: PLR can assess responsiveness despite spontaneous breathing or arrhythmia when flow is measured promptly. It may be unsuitable with unstable spinal injury, position intolerance, or intracranial hypertension. A positive test does not itself prove that additional fluid is beneficial.

Noninvasive and Minimally Invasive Cardiac Output Monitors

Monitoring Modality Mechanism of Action Clinical Advantages Key Limitations in Neuro-ICU

Arterial Pulse Contour Analysis (FloTrac, PiCCO) Derives stroke volume from the systolic portion of the arterial pressure curve ( ∫ P d t \int P\,dt ∫ P d t ) and vascular compliance Continuous, beat-to-beat monitoring; provides real-time S V V SVV S VV and P P V PPV PP V Inaccurate during rapid changes in vascular tone (e.g., aggressive vasopressor titration) unless recalibrated

Bioreactance (Cheetah NICOM) Analyzes frequency phase shift of alternating electrical current across the thoracic cavity Completely non-invasive, no arterial line required Motion artifact; signal distortion in severe chest wall edema or thoracic effusions

Esophageal Doppler Measures blood velocity in the descending aorta via a flexible transesophageal ultrasound probe Continuous stroke volume and flow time corrected ( F T c FTc FT c ); highly responsive Requires sedation/intubation; probe displacement; contraindication in esophageal pathology

Transthoracic Echocardiography (TTE) Velocity-Time Integral ( V T I VTI V T I ) across the Left Ventricular Outflow Tract ( L V O T LVOT L V OT ) Gold standard bedside tool; evaluates biventricular function, valves, and wall motion Intermittent snapshot; operator dependent; poor acoustic windows in trauma or surgical emphysema

Echocardiographic LVOT VTI Calculation

To measure stroke volume ( S V SV S V ) at the bedside with echocardiography:

Measure the diameter ( D D D ) of the L V O T LVOT L V OT on the parasternal long-axis view to compute cross-sectional area: Area = π × ( D / 2 ) 2 = 0.785 × D 2 \text{Area} = \pi \times (D/2)^2 = 0.785 \times D^2 Area = π × ( D /2 ) 2 = 0.785 × D 2 .

Measure the pulsed-wave Doppler velocity-time integral ( V T I L V O T VTI_{LVOT} V T I L V OT ​ ) in the apical five-chamber view.

Calculate stroke volume: S V = Area L V O T × V T I L V O T SV = \text{Area}_{LVOT} \times VTI_{LVOT} S V = Area L V OT ​ × V T I L V OT ​

Normal V T I L V O T VTI_{LVOT} V T I L V OT ​ ranges from 18 – 22 cm 18\text{--}22\text{ cm} 18 – 22 cm . A transient increase in V T I L V O T > 10 – 15 % VTI_{LVOT} > 10\text{--}15\% V T I L V OT ​ > 10 – 15% during a passive leg raise confirms fluid responsiveness.

Disease-Specific Blood Pressure Targets in Neurocritical Care

Blood pressure thresholds vary radically depending on the primary neuropathology, reflecting the opposing risks of ischemia, hematoma expansion, and cerebral edema.

Neuropathology Guideline Benchmark Blood Pressure Target Key Rationale & Clinical Pitfall

Severe Traumatic Brain Injury (TBI) Brain Trauma Foundation (BTF) 4th Edition S B P ≥ 100 mmHg SBP \ge 100\text{ mmHg} SBP ≥ 100 mmHg for age 50–69; S B P ≥ 110 mmHg SBP \ge 110\text{ mmHg} SBP ≥ 110 mmHg for age 15–49 or ≥ 70 \ge 70 ≥ 70 ; C P P 60 – 70 mmHg CPP\ 60\text{--}70\text{ mmHg} CPP 60 – 70 mmHg Secondary hypotension doubles mortality in TBI. Avoid targeting C P P > 70 mmHg CPP > 70\text{ mmHg} CPP > 70 mmHg with aggressive fluids/vasopressors due to increased risk of acute respiratory distress syndrome ( A R D S ARDS A R D S ).

Acute Ischemic Stroke (AIS): Thrombolysis / EVT AHA/ASA Guidelines < 185 / 110 mmHg < 185/110\text{ mmHg} < 185/110 mmHg prior to tPA/TNK; < 180 / 105 mmHg < 180/105\text{ mmHg} < 180/105 mmHg for 24 h post-reperfusion Prevents catastrophic reperfusion hemorrhage and hemorrhagic transformation of ischemic tissue.

Acute Ischemic Stroke: Non-Reperfused AHA/ASA Guidelines Permissive hypertension up to 220 / 120 mmHg 220/120\text{ mmHg} 220/120 mmHg Preserves collateral blood flow to the ischemic penumbra. Treat only if BP > 220 / 120 mmHg \text{BP} > 220/120\text{ mmHg} BP > 220/120 mmHg (lowering by 15 % 15\% 15% in first 24 h) or if active end-organ injury exists (aortic dissection, ACS, pulmonary edema).

Acute Intracerebral Hemorrhage (ICH) 2022 AHA/ASA Guidelines Target SBP 140 mmHg 140\text{ mmHg} 140 mmHg (maintain range 130 – 150 mmHg 130\text{--}150\text{ mmHg} 130 – 150 mmHg ) for presentation SBP 150–220 Limits hematoma expansion within the first 6–24 hours. Avoid SBP < 130 mmHg < 130\text{ mmHg} < 130 mmHg , which significantly increases acute kidney injury and cardiac events without neurological benefit.

aSAH before securing 2023 AHA/ASA Avoid severe hypertension, hypotension, and variability; no universal numeric target is established Individualize to perfusion and the clinical setting

Aneurysmal SAH: Post-Securing / DCI Neurocritical Care Society Guidelines Permissive / Induced Hypertension (titrated to clinical improvement) First-line therapy for symptomatic Delayed Cerebral Ischemia ( D C I DCI D C I ) using vasopressors (norepinephrine) to restore perfusion to vasospastic territories. Euvolemia is maintained; hypervolemia is harmful.

Warning

In acute intracerebral hemorrhage, the ATACH-2 trial demonstrated that intensive, aggressive blood pressure reduction dropping S B P < 130 mmHg SBP < 130\text{ mmHg} SBP < 130 mmHg within 2 hours resulted in an excess rate of renal adverse events ( 9.0 % 9.0\% 9.0% vs 4.0 % 4.0\% 4.0% ) and pulmonary complications without improving functional outcome or mortality. Titrate infusions smoothly to remain within the safe 130 – 150 mmHg 130\text{--}150\text{ mmHg} 130 – 150 mmHg window.

Pressure reference: State whether arterial pressure is referenced at the heart or head and follow the institution’s specified CPP convention. Head elevation creates a hydrostatic difference; targets derived using one convention cannot be transferred silently to the other. An arterial-line MAP may be less affected than systolic pressure by modest damping, but severe obstruction or an incorrect level can still make it inaccurate.